Alpine Woods Capital Investors LLC Invests $3.47 Million in MetLife, Inc. $MET

Key Points

• Alpine Woods Capital Investors acquired 41,057 MetLife shares worth approximately $3.47 million in the second quarter, while institutional investors collectively own 94.99% of the stock.
• MetLife reported quarterly earnings of $2.43 per share, beating estimates of $2.30, with revenue up 10.5% year over year. The board also authorized a $3 billion share-repurchase program covering up to 4.8% of outstanding shares.
• Analysts remain broadly positive, with a consensus “Moderate Buy” rating and a $101.07 price target; MetLife also maintains a quarterly dividend of $0.5925 per share, yielding about 2.4% annually.

Alpine Woods Capital Investors LLC purchased a new stake in shares of MetLife, Inc. (NYSE:MET - Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 41,057 shares of the financial services provider's stock, valued at approximately $3,474,000.

A number of other large investors have also recently made changes to their positions in MET. Activest Wealth Management lifted its holdings in shares of MetLife by 205.8% during the fourth quarter. Activest Wealth Management now owns 315 shares of the financial services provider's stock valued at $25,000 after purchasing an additional 212 shares during the last quarter. Garton & Associates Financial Advisors LLC purchased a new stake in shares of MetLife in the 4th quarter worth approximately $30,000. Gunpowder Capital Management LLC dba Oliver Wealth Management bought a new position in MetLife during the 4th quarter valued at approximately $31,000. Prosperity Bancshares Inc bought a new position in MetLife during the 4th quarter valued at approximately $31,000. Finally, JPL Wealth Management LLC purchased a new position in MetLife during the third quarter valued at $33,000. 94.99% of the stock is currently owned by institutional investors.

MetLife News Roundup

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: DOWLING & PARTN raised its fiscal 2027 earnings estimate for MetLife to $10.85 per share from $10.75. The revision suggests improving analyst expectations for the insurer’s future profitability and is favorable for MET, although the new estimate remains above the broader current-year consensus of $9.70. MetLife FY2027 earnings estimate
• Neutral Sentiment: MetLife declared third-quarter 2026 dividends on several series of preferred stock, including Series A, Series D, Series E and Series F. The payments reinforce the company’s ongoing capital-return commitments, but they primarily affect preferred shareholders and are unlikely to materially change the valuation of MET common shares. MetLife preferred stock dividends
• Neutral Sentiment: MetLife published its 2025 sustainability report, highlighting research and insights related to its environmental, social and governance initiatives. The report may support the company’s long-term reputation with stakeholders, but it is not expected to have an immediate earnings impact. MetLife 2025 sustainability report
• Neutral Sentiment: Several headlines concern MetLife Stadium, including a new stadium CEO, rapid transitions between Jets and Giants games, and upcoming concerts. These stories relate to the sports and entertainment venue—not MetLife, Inc.’s insurance and financial-services operations—and should not materially affect MET stock. MetLife Stadium names new CEO

MetLife Price Performance

NYSE MET opened at $96.83 on Wednesday. The stock has a market capitalization of $62.31 billion, a price-to-earnings ratio of 18.55, a PEG ratio of 0.75 and a beta of 0.78. MetLife, Inc. has a 1-year low of $67.33 and a 1-year high of $100.93. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.20 and a quick ratio of 0.20. The business's fifty day moving average price is $92.00 and its 200-day moving average price is $81.86.

MetLife (NYSE:MET - Get Free Report) last posted its earnings results on Wednesday, August 5th. The financial services provider reported $2.43 earnings per share for the quarter, beating analysts' consensus estimates of $2.30 by $0.13. MetLife had a return on equity of 23.39% and a net margin of 4.57%.The company had revenue of $13.52 billion for the quarter, compared to the consensus estimate of $19.67 billion. During the same quarter in the prior year, the company earned $2.02 earnings per share. MetLife's revenue was up 10.5% on a year-over-year basis. On average, equities analysts predict that MetLife, Inc. will post 9.7 earnings per share for the current year.

MetLife announced that its Board of Directors has initiated a share repurchase plan on Wednesday, August 5th that allows the company to buyback $3.00 billion in shares. This buyback authorization allows the financial services provider to reacquire up to 4.8% of its shares through open market purchases. Shares buyback plans are generally an indication that the company's board of directors believes its stock is undervalued.

MetLife Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 8th. Shareholders of record on Tuesday, August 4th will be issued a dividend of $0.5925 per share. This represents a $2.37 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date of this dividend is Tuesday, August 4th. MetLife's dividend payout ratio is currently 45.40%.

Analysts Set New Price Targets

A number of analysts have weighed in on MET shares. Morgan Stanley raised their price objective on shares of MetLife from $93.00 to $103.00 and gave the company an "overweight" rating in a research note on Monday, July 6th. Jefferies Financial Group increased their price target on shares of MetLife from $97.00 to $103.00 and gave the company a "buy" rating in a report on Friday, July 10th. Weiss Ratings raised shares of MetLife from a "buy (b-)" rating to a "buy (b)" rating in a research report on Monday, June 15th. Wall Street Zen lowered shares of MetLife from a "buy" rating to a "hold" rating in a report on Saturday, May 9th. Finally, TD Cowen upped their price objective on MetLife from $87.00 to $105.00 and gave the company a "buy" rating in a research report on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have given a Hold rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $101.07.

MetLife Company Profile

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source